The general public did not know much about mRNA vaccines a few months ago; now biotech firms like Moderna, BioNTech or CureVac have almost become household brand-names! We spoke this month with Sander Slootweg, Founder and Managing Partner of Forbion – one of the leading biotech investors in Europe. He told us about the incredible…
This month, IPEM had its monthly rendez-vous with Robin Doumar, Managing Partner and Founder of Park Square Capital, one of the largest players in private debt in Europe. We discussed with Robin the state of the private credit market, how the market rebounded, the opportunities he sees in Europe in the coming months and how…
The Kauffmann Foundation is a US foundation with $2.6bn AUM and over $1bn invested in PE/VC funds. Diane Mulcahy, Private Equity Adviser at the Foundation is a lecturer in the Entrepreneurship Division at Babson College, visiting fellow at the Bruegel Institute, and a bestselling author of the “Gig Economy” (Harper Collins, 2016). In 2012, Diane…
LGT Capital Partners’s Q4 performance was its best on record. But even with a vaccine on the horizon, we are not yet out of the woods, says the Managing Partner Ivan Vercoutere From the sharpest-ever decline in equity markets and an unprecedented global lockdown in March, to an explosion of exceptional exits in the closing…
Private equity is being positioned as the villain of the current crisis. But we have an opportunity to reimagine the asset class’s role in society.